HRT Financial’s Advent Technologies ADN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-5,385
Closed -$95K 2325
2023
Q2
$95K Buy
+5,385
New +$130K ﹤0.01% 1979
2022
Q3
Sell
-989
Closed -$74K 2715
2022
Q2
$74K Sell
989
-8,307
-89% -$501K ﹤0.01% 2470
2022
Q1
$647K Buy
+9,296
New +$1.05M ﹤0.01% 1444
2021
Q1
Sell
-2,765
Closed -$1.24M 2631
2020
Q4
$1.24M Sell
2,765
-10,925
-80% -$3.78M 0.02% 510
2020
Q3
$4.25M Buy
+13,690
New +$4.24M 0.12% 118

Other funds holding ADN

HRT Financial's ADN Position: Q3 2023 in Review

HRT Financial sold out of Advent Technologies (ADN) in Q3 2023, closing a stake of 5,385 shares — an estimated $95K sold.

HRT Financial first reported a position in ADN in Q3 2020 and held it in 5 quarters. The position peaked at $4.25M in Q3 2020. 35 funds tracked by Wall St. Rank hold ADN as of Q3 2023.

  • HRT Financial reported no remaining Advent Technologies position as of Q3 2023 after selling out during the quarter.
  • HRT Financial sold 5,385 Advent Technologies shares in Q3 2023, an estimated $95K.
  • HRT Financial first reported a position in Advent Technologies in Q3 2020 and held it in 5 quarters.
  • HRT Financial's Advent Technologies position peaked at $4.25M in Q3 2020.
  • 35 funds tracked by Wall St. Rank held Advent Technologies as of Q3 2023.

Based on HRT Financial's 13F filing for Q3 2023, filed 13 Nov 2023.